{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:32:13Z","timestamp":1790253133557,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673806"],"award-info":[{"award-number":["81673806"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104702"],"award-info":[{"award-number":["82104702"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background and aims<\/jats:title>\n                <jats:p>Drug-induced liver injury (DILI) is a prevalent adverse reaction in clinical settings. However, there is limited research on age-related differences in DILI. We performed a large-scale retrospective study to delineate the characteristics of DILI across different age groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We collected data on a total of 17,946 patients with confirmed DILI hospitalized at the Fifth Medical Center of the People\u2019s Liberation Army (PLA) General Hospital in Beijing, China, from January 1, 2002, to December 31, 2022. The patients were stratified based on age into the following groups: children (&lt;\u200918\u00a0years), young adults (18\u201344\u00a0years), middle-aged individuals (45\u201364\u00a0years), and elderly individuals (\u2265\u200965\u00a0years). We gathered demographic information, medical histories, laboratory results, disease severity assessments, and mortality statistics for all patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, the distribution of DILI cases across different age groups was as follows: 6.57% were children, 24.82% were young adults, 49.06% were middle-aged individuals, and 19.54% were elderly individuals. The percentage of females increased with age, rising from 36.47% in the pediatric group to 60.51% in the elderly group. Notably, central nervous system agents (15.44%) and anti-infectious agents (21.80%) were more commonly associated with DILI in children, while cardiovascular agents (10.58%) and herbal dietary supplements or traditional medicines (H\/TMs) (26.29%) were more prevalent among elderly people with DILI. Among all age groups, hepatocellular-type DILI was more common in the pediatric group (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), whereas cholestatic-type DILI and chronic DILI were more prevalent in the elderly group (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Acute liver failure (ALF) and fatal outcomes were more prevalent in the pediatric and elderly groups, particularly in the pediatric group (2.04%, <jats:italic>p<\/jats:italic>\u2009=\u20090.041; 0.85%, <jats:italic>p<\/jats:italic>\u2009=\u20090.007, respectively).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Children and elderly individuals face a higher risk of adverse outcomes following DILI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s12072-024-10679-1","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T17:01:47Z","timestamp":1718816507000},"page":"1202-1213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Age-related differences in drug-induced liver injury: a retrospective single-center study from a large liver disease specialty hospital in China, 2002\u20132022"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1755-1496","authenticated-orcid":false,"given":"Simiao","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haocheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sici","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,19]]},"reference":[{"issue":"1","key":"10679_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","volume":"5","author":"RJ Andrade","year":"2019","unstructured":"Andrade RJ, Chalasani N, Bj\u00f6rnsson ES, et al. Drug-induced liver injury. Nat Rev Dis Primers. 2019;5(1):58. https:\/\/doi.org\/10.1038\/s41572-019-0105-0","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10679_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.dld.2005.06.004","volume":"38","author":"E Bj\u00f6rnsson","year":"2006","unstructured":"Bj\u00f6rnsson E, Olsson R. Suspected drug-induced liver fatalities reported to the WHO database. Dig Liver Dis. 2006;38(1):33\u201338. https:\/\/doi.org\/10.1016\/j.dld.2005.06.004","journal-title":"Dig Liver Dis"},{"issue":"10","key":"10679_CR3","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1007\/s00204-020-02885-1","volume":"94","author":"M Garcia-Cortes","year":"2020","unstructured":"Garcia-Cortes M, Robles-Diaz M, Stephens C, Ortega-Alonso A, Lucena MI, Andrade RJ. Drug induced liver injury: an update. Arch Toxicol. 2020;94(10):3381\u20133407. https:\/\/doi.org\/10.1007\/s00204-020-02885-1","journal-title":"Arch Toxicol"},{"issue":"1","key":"10679_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1365-2125.2004.02133.x","volume":"58","author":"FJ de Abajo","year":"2004","unstructured":"de Abajo FJ, Montero D, Madurga M, Garc\u00eda Rodr\u00edguez LA. Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol. 2004;58(1):71\u201380. https:\/\/doi.org\/10.1111\/j.1365-2125.2004.02133.x","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"10679_CR5","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","volume":"144","author":"ES Bj\u00f6rnsson","year":"2013","unstructured":"Bj\u00f6rnsson ES, Bergmann OM, Bj\u00f6rnsson HK, Kvaran RB, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013;144(7):1419\u20131425. https:\/\/doi.org\/10.1053\/j.gastro.2013.02.006","journal-title":"Gastroenterology"},{"issue":"9","key":"10679_CR6","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s40264-017-0547-9","volume":"40","author":"M Vega","year":"2017","unstructured":"Vega M, Verma M, Beswick D, et al. The incidence of drug- and herbal and dietary supplement-induced liver injury: preliminary findings from gastroenterologist-based surveillance in the population of the state of delaware. Drug Saf. 2017;40(9):783\u2013787. https:\/\/doi.org\/10.1007\/s40264-017-0547-9","journal-title":"Drug Saf"},{"issue":"3","key":"10679_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12072-017-9793-2","volume":"11","author":"YC Yu","year":"2017","unstructured":"Yu YC, Mao YM, Chen CW, et al. CSH guidelines for the diagnosis and treatment of drug-induced liver injury. Hepatol Int. 2017;11(3):221\u2013241. https:\/\/doi.org\/10.1007\/s12072-017-9793-2","journal-title":"Hepatol Int"},{"issue":"8","key":"10679_CR8","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1053\/j.gastro.2019.02.002","volume":"156","author":"T Shen","year":"2019","unstructured":"Shen T, Liu Y, Shang J, et al. Incidence and etiology of drug-induced liver injury in Mainland China. Gastroenterology. 2019;156(8):2230-2241.e11. https:\/\/doi.org\/10.1053\/j.gastro.2019.02.002","journal-title":"Gastroenterology"},{"issue":"3","key":"10679_CR9","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/bcp.12267","volume":"79","author":"HK Batchelor","year":"2015","unstructured":"Batchelor HK, Marriott JF. Paediatric pharmacokinetics: key considerations. Br J Clin Pharmacol. 2015;79(3):395\u2013404. https:\/\/doi.org\/10.1111\/bcp.12267","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10679_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/03602530902722679","volume":"41","author":"U Klotz","year":"2009","unstructured":"Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67\u201376. https:\/\/doi.org\/10.1080\/03602530902722679","journal-title":"Drug Metab Rev"},{"issue":"3","key":"10679_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1046\/j.1472-8206.2003.00140.x","volume":"17","author":"M Strolin Benedetti","year":"2003","unstructured":"Strolin Benedetti M, Baltes EL. Drug metabolism and disposition in children. Fundam Clin Pharmacol. 2003;17(3):281\u2013299. https:\/\/doi.org\/10.1046\/j.1472-8206.2003.00140.x","journal-title":"Fundam Clin Pharmacol"},{"issue":"4","key":"10679_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11894-021-00804-7","volume":"23","author":"BT Lee","year":"2021","unstructured":"Lee BT, Odin JA, Grewal P. An approach to drug-induced liver injury from the geriatric perspective. Curr Gastroenterol Rep. 2021;23(4):6. https:\/\/doi.org\/10.1007\/s11894-021-00804-7","journal-title":"Curr Gastroenterol Rep"},{"issue":"2","key":"10679_CR13","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.yrtph.2014.09.007","volume":"70","author":"CM Hunt","year":"2014","unstructured":"Hunt CM, Yuen NA, Stirnadel-Farrant HA, Suzuki A. Age-related differences in reporting of drug-associated liver injury: data-mining of WHO safety report database. Regul Toxicol Pharmacol. 2014;70(2):519\u2013526. https:\/\/doi.org\/10.1016\/j.yrtph.2014.09.007","journal-title":"Regul Toxicol Pharmacol"},{"issue":"1","key":"10679_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/ijms17010014","volume":"17","author":"G Danan","year":"2015","unstructured":"Danan G, Teschke R. RUCAM in drug and herb induced liver injury: the update. Int J Mol Sci. 2015;17(1):14. https:\/\/doi.org\/10.3390\/ijms17010014","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10679_CR15","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jhep.2016.12.003","volume":"66","author":"J Wendon","year":"2017","unstructured":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; Clinical practice guidelines panel, Wendon J, et al. EASL clinical practical guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017;66(5):1047\u20131081. https:\/\/doi.org\/10.1016\/j.jhep.2016.12.003","journal-title":"J Hepatol"},{"issue":"1","key":"10679_CR16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jhep.2021.01.029","volume":"75","author":"C Stephens","year":"2021","unstructured":"Stephens C, Robles-Diaz M, Medina-Caliz I, et al. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI registry. J Hepatol. 2021;75(1):86\u201397. https:\/\/doi.org\/10.1016\/j.jhep.2021.01.029","journal-title":"J Hepatol"},{"issue":"7","key":"10679_CR17","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","volume":"148","author":"N Chalasani","year":"2015","unstructured":"Chalasani N, Bonkovsky HL, Fontana R, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015;148(7):1340\u201352.e7. https:\/\/doi.org\/10.1053\/j.gastro.2015.03.006","journal-title":"Gastroenterology"},{"issue":"5","key":"10679_CR18","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/MOP.0000000000000264","volume":"27","author":"MD Amin","year":"2015","unstructured":"Amin MD, Harpavat S, Leung DH. Drug-induced liver injury in children. Curr Opin Pediatr. 2015;27(5):625\u2013633. https:\/\/doi.org\/10.1097\/MOP.0000000000000264","journal-title":"Curr Opin Pediatr"},{"issue":"6","key":"10679_CR19","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","volume":"135","author":"N Chalasani","year":"2008","unstructured":"Chalasani N, Fontana RJ, Bonkovsky HL, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology. 2008;135(6):1924\u20131934. https:\/\/doi.org\/10.1053\/j.gastro.2008.09.011","journal-title":"Gastroenterology"},{"issue":"2","key":"10679_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1053\/jhep.2002.34857","volume":"36","author":"C Sgro","year":"2002","unstructured":"Sgro C, Clinard F, Ouazir K, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology. 2002;36(2):451\u2013455. https:\/\/doi.org\/10.1053\/jhep.2002.34857","journal-title":"Hepatology"},{"issue":"8","key":"10679_CR21","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/j.1365-2036.2006.03117.x","volume":"24","author":"MB De Valle","year":"2006","unstructured":"De Valle MB, Av Klinteberg V, Alem N, Olsson R, Bj\u00f6rnsson E. Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic. Aliment Pharmacol Ther. 2006;24(8):1187\u20131195. https:\/\/doi.org\/10.1111\/j.1365-2036.2006.03117.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10679_CR22","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/ajg.2012.138","volume":"107","author":"KT Suk","year":"2012","unstructured":"Suk KT, Kim DJ, Kim CH, et al. A prospective nationwide study of drug-induced liver injury in Korea. Am J Gastroenterol. 2012;107(9):1380\u20131387. https:\/\/doi.org\/10.1038\/ajg.2012.138","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10679_CR23","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","volume":"70","author":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; Clinical Practice Guideline Panel: Chair:; Panel members; EASL Governing Board representative","year":"2019","unstructured":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; Clinical Practice Guideline Panel: Chair:; Panel members; EASL Governing Board representative. EASL Clinical Practice Guidelines: Drug-induced liver injury. J Hepatol. 2019;70(6):1222\u20131261. https:\/\/doi.org\/10.1016\/j.jhep.2019.02.014","journal-title":"J Hepatol"},{"issue":"9","key":"10679_CR24","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1111\/liv.15262","volume":"42","author":"X Li","year":"2022","unstructured":"Li X, Tang J, Mao Y. Incidence and risk factors of drug-induced liver injury. Liver Int. 2022;42(9):1999\u20132014. https:\/\/doi.org\/10.1111\/liv.15262","journal-title":"Liver Int"},{"issue":"1","key":"10679_CR25","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/hep.28813","volume":"65","author":"VJ Navarro","year":"2017","unstructured":"Navarro VJ, Khan I, Bj\u00f6rnsson E, Seeff LB, Serrano J, Hoofnagle JH. Liver injury from herbal and dietary supplements. Hepatology. 2017;65(1):363\u2013373. https:\/\/doi.org\/10.1002\/hep.28813","journal-title":"Hepatology"},{"issue":"2","key":"10679_CR26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s12072-021-10144-3","volume":"15","author":"H Devarbhavi","year":"2021","unstructured":"Devarbhavi H, Aithal G, Treeprasertsuk S, et al. Drug-induced liver injury: asia pacific association of study of liver consensus guidelines. Hepatol Int. 2021;15(2):258\u2013282. https:\/\/doi.org\/10.1007\/s12072-021-10144-3","journal-title":"Hepatol Int"},{"issue":"7","key":"10679_CR27","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","volume":"134","author":"W Cao","year":"2021","unstructured":"Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 2021;134(7):783\u2013791. https:\/\/doi.org\/10.1097\/CM9.0000000000001474","journal-title":"Chin Med J (Engl)"},{"issue":"12","key":"10679_CR28","doi-asserted-by":"publisher","first-page":"758","DOI":"10.2471\/BLT.22.288420","volume":"100","author":"M Pan","year":"2022","unstructured":"Pan M, Hu S, Zhang J, Xiang C, Babar ZU, Yang C. Procurement of medicines to treat cancer, 2015\u20132020. China Bull World Health Organ. 2022;100(12):758\u2013768. https:\/\/doi.org\/10.2471\/BLT.22.288420","journal-title":"China Bull World Health Organ"},{"issue":"3","key":"10679_CR29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1053\/jinf.2002.1078","volume":"46","author":"S Hu","year":"2003","unstructured":"Hu S, Liu X, Peng Y. Assessment of antibiotic prescription in hospitalised patients at a Chinese university hospital. J Infect. 2003;46(3):161\u2013163. https:\/\/doi.org\/10.1053\/jinf.2002.1078","journal-title":"J Infect"},{"issue":"2","key":"10679_CR30","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/MPG.0b013e31821d6cfd","volume":"53","author":"JP Molleston","year":"2011","unstructured":"Molleston JP, Fontana RJ, Lopez MJ, Kleiner DE, Gu J, Chalasani N. Drug-Induced Liver Injury Network. Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study. J Pediatr Gastroenterol Nutr. 2011;53(2):182\u2013189. https:\/\/doi.org\/10.1097\/MPG.0b013e31821d6cfd","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10","key":"10679_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108970","volume":"9","author":"K Star","year":"2014","unstructured":"Star K, Edwards IR, Choonara I. Valproic acid and fatalities in children: a review of individual case safety reports in VigiBase. PLoS ONE. 2014;9(10): e108970. https:\/\/doi.org\/10.1371\/journal.pone.0108970","journal-title":"PLoS ONE"},{"issue":"4","key":"10679_CR32","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1001\/jamainternmed.2015.8581","volume":"176","author":"DM Qato","year":"2016","unstructured":"Qato DM, Wilder J, Schumm LP, Gillet V, Alexander GC. Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011. JAMA Intern Med. 2016;176(4):473\u2013482. https:\/\/doi.org\/10.1001\/jamainternmed.2015.8581","journal-title":"JAMA Intern Med"},{"issue":"16","key":"10679_CR33","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1001\/archinte.167.16.1752","volume":"167","author":"TJ Moore","year":"2007","unstructured":"Moore TJ, Cohen MR, Furberg CD. Serious adverse drug events reported to the food and drug administration, 1998\u20132005. Arch Intern Med. 2007;167(16):1752\u20131759. https:\/\/doi.org\/10.1001\/archinte.167.16.1752","journal-title":"Arch Intern Med"},{"issue":"8\u20139","key":"10679_CR34","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.exger.2005.06.009","volume":"40","author":"DL Schmucker","year":"2005","unstructured":"Schmucker DL. Age-related changes in liver structure and function: Implications for disease? Exp Gerontol. 2005;40(8\u20139):650\u2013659. https:\/\/doi.org\/10.1016\/j.exger.2005.06.009","journal-title":"Exp Gerontol"},{"issue":"3","key":"10679_CR35","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/MOG.0000000000000176","volume":"31","author":"IH Kim","year":"2015","unstructured":"Kim IH, Kisseleva T, Brenner DA. Aging and liver disease. Curr Opin Gastroenterol. 2015;31(3):184\u2013191. https:\/\/doi.org\/10.1097\/MOG.0000000000000176","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"10679_CR36","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/hep.26208","volume":"58","author":"M Chen","year":"2013","unstructured":"Chen M, Borlak J, Tong W. High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury. Hepatology. 2013;58(1):388\u2013396. https:\/\/doi.org\/10.1002\/hep.26208","journal-title":"Hepatology"},{"issue":"10","key":"10679_CR37","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/ajg.2015.283","volume":"110","author":"RJ Fontana","year":"2015","unstructured":"Fontana RJ, Hayashi PH, Barnhart H, et al. Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury. Am J Gastroenterol. 2015;110(10):1450\u20131459. https:\/\/doi.org\/10.1038\/ajg.2015.283","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10679_CR38","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1053\/hupa.2002.128060","volume":"33","author":"R Saxena","year":"2002","unstructured":"Saxena R, Hytiroglou P, Thung SN, Theise ND. Destruction of canals of Hering in primary biliary cirrhosis. Hum Pathol. 2002;33(10):983\u2013988. https:\/\/doi.org\/10.1053\/hupa.2002.128060","journal-title":"Hum Pathol"},{"issue":"5","key":"10679_CR39","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1002\/hep.24613","volume":"54","author":"AS Gouw","year":"2011","unstructured":"Gouw AS, Clouston AD, Theise ND. Ductular reactions in human liver: diversity at the interface. Hepatology. 2011;54(5):1853\u20131863. https:\/\/doi.org\/10.1002\/hep.24613","journal-title":"Hepatology"},{"issue":"5","key":"10679_CR40","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jpeds.2005.12.051","volume":"148","author":"RH Squires Jr","year":"2006","unstructured":"Squires RH Jr, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148(5):652\u2013658. https:\/\/doi.org\/10.1016\/j.jpeds.2005.12.051","journal-title":"J Pediatr"},{"issue":"4","key":"10679_CR41","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/hep.24527","volume":"54","author":"H Devarbhavi","year":"2011","unstructured":"Devarbhavi H, Karanth D, Prasanna KS, Adarsh CK, Patil M. Drug-Induced liver injury with hypersensitivity features has a better outcome: a single-center experience of 39 children and adolescents. Hepatology. 2011;54(4):1344\u20131350. https:\/\/doi.org\/10.1002\/hep.24527","journal-title":"Hepatology"},{"issue":"12","key":"10679_CR42","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1016\/j.apsb.2022.04.019","volume":"12","author":"J Wang","year":"2022","unstructured":"Wang J, Song H, Ge F, et al. Landscape of DILI-related adverse drug reaction in China Mainland. Acta Pharm Sin B. 2022;12(12):4424\u20134431. https:\/\/doi.org\/10.1016\/j.apsb.2022.04.019","journal-title":"Acta Pharm Sin B"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10679-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-024-10679-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10679-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T06:21:27Z","timestamp":1722666087000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-024-10679-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,19]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10679"],"URL":"https:\/\/doi.org\/10.1007\/s12072-024-10679-1","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,19]]},"assertion":[{"value":"15 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Simiao Yu, Jiahui Li, Tingting He, Haocheng Zheng, Sici Wang, Yongqiang Sun, Liping Wang, Jing Jing, Ruilin Wang, the authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}